Crohn's disease belongs to a group of conditions known as inflammatory bowel diseases (IBD). This chronic condition causes ...

Moonlake described sonelokimab as a tri-specific, balanced IL-17A/F inhibitor with an albumin binding site, which has the potential to facilitate deep tissue penetration in the skin and joints.

It's common to describe getting a good night's rest by saying we've had a really deep sleep. But in reality, actual deep sleep is just a portion of the 7 to 9 hours sleep that's recommended for ...